Clinical Trial Update: Efficacy Study of Pharmacokinetic(PK)/Pharmacodynamic(PD) Relationship of Monotherapy MORAb-004 in Metastatic Melanoma [Phase 2]

View source ↗

Summary

Phase 2 study assessing PK/PD relationship of MORAb-004 monotherapy in metastatic melanoma has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• MORAb-004

Snippet

Sponsor: Eisai Inc. | Conditions: Metastatic Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2021-09-01